A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia

Abstract

We conduct a comparative cost-effectiveness and budget impact analysis of atypical antipsychotics for the treatment of schizophrenia - sertindole versus quetiapine, paliperidone. The primary outcome of interest was rehospitalization rates. The cost of the annual treatment of patients with schizophrenia in the outpatient setting was calculated, costs of hospital readmission and total costs.

Keywords

• фармакоэкономический анализ
• анализ затраты-эффективность
• анализ влияния на бюджет
• атипичные антипсихотики
• шизофрения
• сертиндол
• частота повторных госпитализаций
• pharmacoeconomics analysis
• cost-effectiveness analysis
• budget impact analysis
• atypical antipsychotics
• schizophrenia
• sertindole
• rehospitalization rate